PDS Biotechnology Corp Capital Expenditures
PDS Biotechnology Corp (PDSB) reported Capital Expenditures of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-30
- PDS Biotechnology Corp payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
- PDS Biotechnology Corp payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00.
- PDS Biotechnology Corp payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $1.00.
- PDS Biotechnology Corp payments to acquire property, plant, and equipment for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PDS Biotechnology Corp payments to acquire property, plant, and equipment for fiscal 2024 was $29.00K.
- PDS Biotechnology Corp payments to acquire property, plant, and equipment for fiscal 2023 was $0.00.
- PDS Biotechnology Corp payments to acquire property, plant, and equipment for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.00 derived: sum of 2 quarters · filed 2026-03-30 | $29.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $29.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $29.00K 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $0.00 10-K · filed 2025-03-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 derived: sum of 2 quarters · filed 2019-02-21 | $0.00 derived: sum of 3 quarters · filed 2019-02-21 | $0.00 10-K · filed 2019-02-21 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | $27.97K derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $0.00 10-Q · filed 2018-08-01 | $27.97K derived: sum of 3 quarters · filed 2019-02-21 | $83.06K derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-01 | $27.97K derived: sum of 2 quarters · filed 2019-02-21 | $83.06K derived: sum of 3 quarters · filed 2019-02-21 | $99.44K derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-12-31 | $27.97K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $83.06K derived: sum of 2 quarters · filed 2019-02-21 | $99.44K derived: sum of 3 quarters · filed 2019-02-21 | $188.72K 10-K · filed 2019-02-21 |
| 2017-09-30 | $55.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $71.47K derived: sum of 2 quarters · filed 2018-11-01 | $160.75K 10-Q · filed 2018-11-01 | $508.05K derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | $16.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $105.66K 10-Q · filed 2018-08-01 | $452.96K derived: sum of 3 quarters · filed 2018-08-01 | $597.05K derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $89.28K 10-Q · filed 2018-05-01 | $436.58K derived: sum of 2 quarters · filed 2018-05-01 | $580.67K derived: sum of 3 quarters · filed 2018-05-01 | $698.70K derived: sum of 4 quarters · filed 2018-05-01 |
| 2016-12-31 | $347.30K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $491.39K derived: sum of 2 quarters · filed 2018-03-01 | $609.42K derived: sum of 3 quarters · filed 2018-03-01 | $686.71K 10-K · filed 2018-03-01 |
| 2016-09-30 | $144.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $262.12K derived: sum of 2 quarters · filed 2017-11-01 | $339.41K 10-Q · filed 2017-11-01 | $845.07K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $118.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $195.32K 10-Q · filed 2017-08-01 | $700.98K derived: sum of 3 quarters · filed 2018-03-01 | $1.05M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $77.29K 10-Q · filed 2017-05-03 | $582.95K derived: sum of 2 quarters · filed 2018-03-01 | $935.20K derived: sum of 3 quarters · filed 2018-03-01 | $1.30M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $505.66K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $857.92K derived: sum of 2 quarters · filed 2018-03-01 | $1.22M derived: sum of 3 quarters · filed 2018-03-01 | $1.31M 10-K · filed 2018-03-01 |
| 2015-09-30 | $352.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $713.35K derived: sum of 2 quarters · filed 2016-11-01 | $799.42K 10-Q · filed 2016-11-01 | $1.42M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $361.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $447.17K 10-Q · filed 2016-08-03 | $1.07M derived: sum of 3 quarters · filed 2017-03-02 | |
| 2015-03-31 | $86.08K 10-Q · filed 2016-05-03 | $705.72K derived: sum of 2 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $619.64K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $884.79K 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $265.15K 10-Q · filed 2015-11-06 | |||
| 2013-12-31 | $136.89K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |